Novem Group’s Alerian MLP ETF AMLP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.02M Buy
19,681
+549
+3% +$28.8K 0.1% 187
2026
Q1
$1.01M Sell
19,132
-12,203
-39% -$621K 0.12% 163
2025
Q4
$1.47M Buy
31,335
+1,929
+7% +$90.3K 0.17% 106
2025
Q3
$1.38M Sell
29,406
-115
-0.4% -$5.56K 0.16% 115
2025
Q2
$1.44M Buy
29,521
+1,040
+4% +$50.4K 0.18% 96
2025
Q1
$1.48M Buy
28,481
+667
+2% +$34.2K 0.21% 89
2024
Q4
$1.34M Buy
+27,814
New +$1.34M 0.2% 92

Other funds holding AMLP

Novem Group's AMLP Position: Q2 2026 in Review

Novem Group increased its Alerian MLP ETF (AMLP) stake by 2.9% in Q2 2026, buying an estimated $28.8K and bringing the position to 19,681 shares worth $1.02M. The position accounts for 0.1% of the portfolio, ranked #187.

Novem Group first reported a position in AMLP in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.48M in Q1 2025. 808 funds tracked by Wall St. Rank hold AMLP as of Q2 2026.

  • Novem Group held 19,681 shares of Alerian MLP ETF worth $1.02M as of Q2 2026.
  • Novem Group bought 549 Alerian MLP ETF shares in Q2 2026, an estimated $28.8K.
  • Alerian MLP ETF made up 0.1% of Novem Group's portfolio in Q2 2026, its #187 holding.
  • Novem Group first reported a position in Alerian MLP ETF in Q4 2024 and has held it in 7 quarters since.
  • Novem Group's Alerian MLP ETF position peaked at $1.48M in Q1 2025.
  • 808 funds tracked by Wall St. Rank held Alerian MLP ETF as of Q2 2026.

Based on Novem Group's 13F filing for Q2 2026, filed 21 Jul 2026.